Sixteen new designs o f antagonists o f the luteinizing h o rm o n e releasing h o rm o n e (L H R H ) with histidine in position 8 were synthesized, because this p osition is critical b o th for a n tio v u latory activity an d the side effect o f histam ine release. T he m ost p o ten t a n tag o n ist was N A c D Q a l-D p C lP h e -D 3 P a l-S e r -c P z A C A la -D P ic L y s -L e u -H is -P r o -D A la N H 2, which show ed 33% A O A at 0.25 //g. The histam ine release was rem ark ab ly negligible by an E D 50 o f 308 z^g/ml which is su p erio r to 186//g/m l for L H R H and co m p arab le to 300 for A ntide. 
Introduction
Tw o aim s for the synthesis o f antagonists o f the luteinizing h orm one releasing horm one (L H R H ), a decapeptide w ith the sequence p G l u -H i s -T r p -S er-T y r-G l y -L e u -A r g -P r o -G l y N H 2 [1, 2] , are the control o f fertility by the blockade o f ovu lation, and the co n tro l o f horm one-dependent tu m ors.
Early L H R H antag o n ists like N a l-A r g , N A c D N a l -D p F P h e -D T r p -S e r -T y r -D A r g -L e u -A r g -P r o -D A l a N H 2 [3] , though p otent in an tio v u lato ry assays were doubtful for clinical trials because o f the undesired side effects. This type o f analog, featuring a sequence o f lypophilic N -term inal D -am ino acids and the two cationic charges o f D A rg 6 and A rg 8 caused transient edem a o f the face and extrem ities in the rat [4] , which was ap p aren tly caused by histam ine released from m ast cells [5, 6] . Since this result em phasis was di rected tow ard dim inishing histam ine release m ain ly by decreasing basicity in position 6 an d /o r 8. The presence o f A rg, naturally occurring in posi tion 8 o f L H R H , was successfully replaced by isopropyllysine [7] .
A ntide, N A c D N a l-D p C lP h e -D P a l-S e rNicLys -D N icL ys -Leu -1 Lys -Pro -D A laN H 2 was the first L H R H an tag o n ist w ith the exception-* R eprint requests to Prof. D r. K. Folkers.
Verlag der Z eitschrift für N atu rfo rsch u n g , D-W -7400 T übingen 0 9 3 2 -0 7 7 6 /9 3 /0 6 0 0 -0 8 1 2 /$ 01.00/0 al very low E D 50 value for histam ine release of over 300 //g/m l [8, 9] , U n fo rtu n ately , designs o f new analogs which re sult in dim inished histam ine release are very often far less po ten t a n tio v u lato ry analogs [10] .
In this study, we have em phasized position 8 in our search for antagonists w hich are safe and p o tent.
Experimental

M a te r ia ls
All n atu ral Boc-am ino acids were obtained from A dvanced C hem T ech, Louisville, K entucky. B o c -P ic L y s [11, 12] an d B o c-cP z A C A la (12) were synthesized as described.
P e p tid e sy n th e sis
The peptides were synthesized by the solidphase m ethod using a sta n d ard protocol [13] ex cept th a t D IE A was used instead o f T E A in the neutralization step, and a reversed addition o f D C C and the am ino acid was used [14] , The benzhydrylam ine hydrochloride resin w as from A dvanced C hem tech and h ad a nitro g en content o f about 0.5 m m ol/g. C leavage o f the peptide from the resin with co n co m itan t d ep ro tectio n o f all side chain protection w as achieved by treatm en t w ith doubly distilled H F(1) at 0 °C in the presence o f 10% /?-cresol for 1 h. The H F w as th en e v a p o ra t ed, in vacuo, first by a w ater a sp ira to r, an d then at high vacuum overnight.
Purification and characterization
The residue from the H F step was extracted w ith ether four tim es to rem ove n o n-peptide side products. The peptides were then extracted w ith aqueous acetic acid and the ex tract was lyophilized.
Purification was achieved by gel filtratio n on Sephadex G 25 w ith 6% acetic acid as the eluant fol lowed by ch ro m ato g rap h y on S ephadex L H 20. The solvent system was w a te r : n -b u ta n o l: acetic a c id : m ethanol 9 0 :1 0 :1 0 :8 .
The purified peptides show ed single spots on T LC on EM 0.25 m m silica gel plates in four dif ferent solvent system s ( Table I) .
The purity was fu rth er checked by analytical H PL C using a W aters in stru m en t w ith 660 solvent program m er an d a V ydac C 18 p eptide colum n, 25x3.6 mm i. 
T able I. C h ro m ato g rap h ic d ata on L H R H antagonists.
A nalog # a ~ R fA A m ino acid analyses were carried out on a Beck m an 118 CL A m ino Acid A nalyzer following stan d ard procedures [15] . The results were in agreem ent with theory w ithin the limits o f experi m ental error. U n n atu ral am ino acids were detect ed qualitatively w ith the exception o f 3 Pal which was quantified (Table II) 
B io lo g ic a l a ss a y s
The A O A was determ ined in rats as reported [16] . T he in vitro histam ine release test in rat m ast cells was perform ed, as described [17, 18] and the results are repo rted as E D 50 values which is the co n cen tratio n in //g/m l th at releases 50% o f the to tal releasable histam ine.
Results and Discussion
A c tiv itie s f o r in h ib itio n o f o v u la tio n in ra ts
As previously recognized, A rg in position 8 can frequently increase the potency o f A O A , but also frequently increases the release o f histam ine [19] . A replacem ent o f A rg8 is sought, and H is8 is of priority.
Sixteen new analogs featuring histidine in posi tion 8 have been synthesized particularly to test for degree o f histam ine release.
C hanges were m ade in positions 1, 5 and 6 o f the follow ing sequence: N A c( ) '-D p C l P h e -D 3 P a l -S e r -( )5-( )6-L e u -H i s -P r o -D A la N H 2.
The peptides were divided into eight groups, each of which co ntained two peptides o f the same design, but w ith a different substituent in position 1. D N al has been alm ost exclusively used in position 1 of L H R H an tag o n ists since it was first introduced by H o rv ath e t al. [20] , and was com pared with D Q al w hich was introduced by Ljungqvist e t al. [12] . Table III show s the A O A d a ta for the sixteen a n a logs at the 0.25 or 0.5 //g /ra t dose levels, and also the E D 50 values for the m ost p otent peptides.
A nalog 1 was designed from o u r previous suc cessful analogs w ith cP zA C A la5 [12] , and showed 33% A O A at 0.25 //g and 45% at 0.5 /ig, and its E D 50 was over 300 jüg/ml. 
Comparison o f analogs with H is8, Arg8, and IL ys8
The 
